Genetic polymorphism in cytochrome P450 7A1 and risk of colorectal cancer: The Fukuoka colorectal cancer study

Cancer Research

Volumn 65, Issue 7, 2005, Pages 2979-2982

  Hagiwara, Tomoko ^a   Kono, Suminori ^a   Yin, Guang ^a   Toyomura, Kengo ^a   Nagano, Jun ^a   Mizoue, Tetsuya ^a   Mibu, Ryuichi ^a   Tanaka, Masao ^a   Kakeji, Yoshihiro ^a   Maehara, Yoshihiko ^a   Okamura, Takeshi ^b   Ikejiri, Kouji ^c   Futami, Kitaroh ^d   Yasunami, Youichi ^e   Maekawa, Takafumi ^e   Takenaka, Kenji ^f   Ichimiya, Hitoshi ^g   Imaizumi, Nobutoshi ^h  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^d Fukuoka University Chikushi Hospital   (Japan)

^e FUKUOKA UNIVERSITY   (Japan)

^f Fukuoka City Hospital   (Japan)

^g HAMANOMACHI HOSPITAL   (Japan)

^h FUKUOKA RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL 7ALPHA MONOOXYGENASE;

ADULT; AGED; ARTICLE; ASCENDING COLON; CANCER INCIDENCE; CANCER RISK; COLON; COLON CANCER; COLORECTAL CANCER; COMMUNITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DESCENDING COLON; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZATION; RECTUM; RECTUM CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; BILE ACIDS AND SALTS; CASE-CONTROL STUDIES; CHOLESTEROL 7-ALPHA-HYDROXYLASE; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 20144389862     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3872     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 2001;94:153-6.
2. Kono S. Dietary factors for gastrointestinal cancers: a worldwide overview. Gann Monogr Cancer Res 1996;44:29-39.
3. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Cancer incidence in five continents, Vol. VIII, IARC Scientific Publications, No. 155. IARC. Lyon; 2002.
4. Narisawa T, Magadia NE, Weisburger JH, Wynder EL. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N′-nitro-N-nitrosoguanidine in rats. J Natl Cancer Inst 1974;53:1093-7.
5. Reddy BS, Narasawa T, Weisburger JH, Wynder EL. Promoting effect of sodium deoxycholate on colon adenocarcinomas in germ-free rats. J Natl Cancer Inst 1976;56:441-2.
6. Qiao D, Chen W, Stratagoules ED, Martinez JD. Bile acid-induced activation of activator protein-1 requires both extracellular signal-regulated kinase and protein kinase C signaling. J Biol Chem 2000;275:15090-8.
7. Milovic V, Teller IC, Faust D, Caspary WF, Stein J. Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation. Eur J Clin Invest 2002;32:29-34.
8. Reddy BS, Wynder EL. Large-bowel carcinogenesis: fecal constituents of populations with diverse incidence rates of colon cancer. J Natl Cancer Inst 1973;50:1437-42.
9. Wynder EL, Reddy BS. Metabolic epidemiology of colorectal cancer. Cancer 1974;34:801-6.
10. Hill MJ, Drasar BS, Williams RE, et al. Faecal bile-acids and clostridia in patients with cancer of the large bowel. Lancet 1975;1:535-9.
11. Reddy BS, Wynder EL. Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer 1977;39:2533-9.
12. Bayerdörffer E, Mannes GA, Richter WO, et al. Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology 1993;104:145-51.
13. Bayerdörffer E, Mannes GA, Ochsenkühn T, Dirschedl P, Wiebecke B, Paumgartner G. Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut 1995;36:268-73.
14. Blackwood A, Murray WR, Mackay C, Calman KC. Fecal bile acids and clostridia in the aetiology of colorectal and breast cancer. Br J Cancer 1978;38:175.
15. Mudd DG, McKelvey ST, Norwood W, Elmore DT. Carcinoma of the large bowel and faecal bile acids. Br J Surg 1979;66:355.
16. Murray WR, Blackwood A, Calman KC, Mackay C. Faecal bile acids and clostridia in the aetiology of colorectal cancer. Br J Surg 1979;66:364.
17. Costarelli V, Key TJ, Appleby PN, Allen DS, Fentiman IS, Sanders TA. A prospective study of serum bile acid concentrations and colorectal cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer 2002;86:174-4.
18. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 1993;105:130-41.
19. Reid FD, Mercer PM, Harrison M, Bates T. Cholecystectomy as a risk factor for colorectal cancer: a meta-analysis. Scand J Gastroenterol 1996;31:160-9.
20. Pomare EW, Heaton KW. The effect of cholecystectomy on bile salt metabolism. Gut 1973;14:753-62.
21. Hepner GW, Hofmann AF, Malagelada JR, Szczepanik PA, Klein PD. Increased bacterial degradation of bile acids in cholecystectomized patients. Gastroenterology 1974;66:556-64.
22. Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC. Linkage between cholesterol 7α-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest 1998;101:1283-91.
23. Couture P, Otvos JD, Cupples LA, Wilson PW, Schaefer EJ, Ordovas JM. Association of the A-204C polymorphism in the cholesterol 7α-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J Lipid Res 1999;40:1883-9.
24. Han Z, Heath SC, Shmulewitz D, et al. Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia. Am J Med Genet 2002;110:234-42.
25. Kono S, Toyomura K, Yin G, Nagano J, Mizoue T. A case-control study of colorectal cancer in relation to lifestyle factors and genetic polymorphisms: design and conduct of the Fukuoka colorectal cancer study. Asian Pac J Cancer Prev 2004;5:393-400.
26. Smith DG, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
27. Wheatley K, Gray R. Mendelian randomization - an update on its use to evaluate allogeneic stem cell transplantation in leukaemia. Int J Epidemiol 2004;33:15-7.
28. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361:593-604.
29. Rose G, Blackburn H, Keys A, et al. Colon cancer and blood-cholesterol. Lancet 1974;1:181-3.
30. Law MR, Thompson SG. Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies. Cancer Causes Control 1991;2:253-61.
31. Nomura AM, Stemmermann GN, Chyou PH. Prospective study of serum cholesterol levels and large-bowel cancer. J Natl Cancer Inst 1991;83:1403-7.
32. Kervinen K, Södervik H, Mäkelä J, et al. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology 1996;110:1785-90.
33. Reddy BS. Diet and excretion of bile acids. Cancer Res 1981;41:3766-8.
34. Reddy BS. Dietary fat and colon cancer: animal model studies. Lipids 1992;27:807-13.
35. McKeown-Eyssen GE, Bright-See E. Dietary factors in colon cancer: international relationships. Nutr Cancer 1984;6:160-70.
36. Kono S. Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur J Cancer Prev 2004;13:127-32.
37. World Cancer Research Fund and American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 1997.